Table 3 Clinical and echocardiographic characteristics of study population at follow-up
|  | Overall (N = 134) | RTF progression (N = 39) | No FTR progression (N = 94) | p value for trend |
|---|---|---|---|---|
Age, years; mean ± SD (range) | 59.7 ± 11.5 [30–94] | 60.5 ± 12.5 [38–94] | 59.3 ± 11.2 [30–89] | 0.356 |
Gender (Male) | 105 (78.4) | 32 (82.1) | 73 (76.8) | 0.06 |
LA Area, mm (Range) | 39.53 ± 9.2 [20–73] | 42.9 ± 10.6 [23–73] | 35.61 ± 7.0 [20–53] | 0.06 |
LVIDD, mm | 56.2 ± 7.2 [42–72] | 58.9 ± 7.3 [43–70] | 53.1 ± 6.1 [42–64] | 0.05 |
LVEF, % | 45.1 ± 10.2 [20–65] | 40. 1 ± 10.3 [20–58] | 50.6 ± 7.3 [30–65] |  < 0.0001 |
RV FAC, % | 27.0 ± 6.1 [10–38] | 23.1 ± 6.9 [10–37] | 30.50 ± 3.8 [23–38] | 0.002 |
RV dysfunction > 2, n (%) | 40 (29.9) | 22 (56.4) | 3 (4.2) |  < 0.0001 |
Mean sPAP, mm Hg | 38.5 ± 12.3 [19–66] | 43.6 ± 11.62 [22–65] | 31.6 ± 8.4 [19–59] |  < 0.0001 |
PHT ≥ Moderate, n (%) | 51 (38.1) | 23 (59) | 9 (12.5) | 0.001 |
MR > 2, n (%) | 46 (34.3) | 36 (78.3) | 10 (11.4) |  < 0.0001 |
Echocardiographic Groupa |  < 0.0001 | |||
Group 1 | Â | 0 (0) | 32 (69.6) | Â |
Group 2 | Â | 5 (5.7) | 4 (8.7) | Â |
Group 3 | Â | 9 (10.2) | 5 (10.9) | Â |
Group 4 | Â | 74 (84.1) | 5 (10.5) | Â |